DYADIC INTERNATIONAL INC (DYAI) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth No data.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth No data.
28/69
2.0 / 5 stars
All 69 Win/Lose results and 51 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 1 wins, 9 losses, 2 no dataLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseDYAI / S&P 9.76% / 15.20% |
LoseDYAI / S&P -8.05% / 15.00% |
LoseDYAI / S&P 21.05% / 50.40% |
| 2026-Q10/3 |
LoseDYAI / S&P -12.77% / -4.33% |
LoseDYAI / S&P 7.13% / 11.30% |
LoseDYAI / S&P 15.00% / 27.70% |
| 2025-Q40/2 |
LoseDYAI / S&P -20.34% / 2.65% |
LoseDYAI / S&P -11.59% / 9.00% |
No dataDYAI / S&P / 13.40% |
| 2025-Q31/2 |
WinDYAI / S&P 19.19% / 8.12% |
LoseDYAI / S&P -0.66% / 4.61% |
No dataDYAI / S&P / 13.45% |
| 2025-Q21/2 |
LoseDYAI / S&P -26.67% / 10.94% |
WinDYAI / S&P 129.20% / 4.83% |
No dataDYAI / S&P / 10.63% |
| 2025-Q11/2 |
LoseDYAI / S&P -22.86% / -4.27% |
WinDYAI / S&P 57.59% / 4.98% |
No dataDYAI / S&P / 10.57% |
| 2024-Q42/2 |
WinDYAI / S&P 68.27% / 2.41% |
WinDYAI / S&P 20.58% / 5.25% |
No dataDYAI / S&P / 6.15% |
| 2024-Q31/2 |
LoseDYAI / S&P -29.73% / 5.89% |
WinDYAI / S&P 13.82% / 5.89% |
No dataDYAI / S&P / 6.11% |
| 2024-Q20/2 |
LoseDYAI / S&P -11.38% / 4.28% |
LoseDYAI / S&P -47.53% / 5.38% |
No dataDYAI / S&P / 5.12% |
| 2024-Q10/2 |
LoseDYAI / S&P 3.73% / 10.56% |
LoseDYAI / S&P -30.82% / 5.71% |
No dataDYAI / S&P / 5.59% |
| 2023-Q40/2 |
LoseDYAI / S&P -16.15% / 11.69% |
LoseDYAI / S&P -1.07% / 6.81% |
No dataDYAI / S&P / 7.78% |
| 2023-Q32/2 |
WinDYAI / S&P -0.52% / -3.27% |
WinDYAI / S&P 18.25% / 7.52% |
No dataDYAI / S&P / -5.03% |
| 2023-Q21/2 |
LoseDYAI / S&P 8.43% / 8.74% |
WinDYAI / S&P 48.65% / 9.50% |
No dataDYAI / S&P / -8.57% |
| 2023-Q12/2 |
WinDYAI / S&P 44.72% / 7.50% |
WinDYAI / S&P 25.78% / 10.77% |
No dataDYAI / S&P / -15.69% |
| 2022-Q40/2 |
LoseDYAI / S&P -35.60% / 7.56% |
LoseDYAI / S&P -99.37% / 11.88% |
No dataDYAI / S&P / -17.99% |
| 2022-Q30/2 |
LoseDYAI / S&P -37.38% / -4.88% |
LoseDYAI / S&P -99.46% / 13.47% |
No dataDYAI / S&P / -1.41% |
| 2022-Q21/2 |
WinDYAI / S&P 1.33% / -16.10% |
LoseDYAI / S&P -99.50% / 13.71% |
No dataDYAI / S&P / 11.04% |
| 2022-Q10/2 |
LoseDYAI / S&P -33.41% / -4.60% |
LoseDYAI / S&P -99.44% / 15.97% |
No dataDYAI / S&P / 42.23% |
| 2021-Q41/2 |
LoseDYAI / S&P -18.71% / 11.03% |
WinDYAI / S&P 28769.30% / 15.00% |
No dataDYAI / S&P / 96.40% |
| 2021-Q32/2 |
WinDYAI / S&P 54.87% / 0.58% |
WinDYAI / S&P 27280.04% / 10.77% |
No dataDYAI / S&P / 69.42% |
| 2021-Q21/2 |
LoseDYAI / S&P -34.61% / 8.55% |
WinDYAI / S&P 26659.37% / 6.58% |
No dataDYAI / S&P / 51.81% |
| 2021-Q11/2 |
LoseDYAI / S&P 2.04% / 6.17% |
WinDYAI / S&P 28872.99% / -1.06% |
No dataDYAI / S&P / 7.39% |
| 2020-Q40/2 |
LoseDYAI / S&P -28.93% / 12.15% |
LoseDYAI / S&P -4.71% / -3.72% |
No dataDYAI / S&P / -33.42% |
| 2020-Q30/2 |
LoseDYAI / S&P -12.59% / 8.93% |
LoseDYAI / S&P -12.69% / -2.04% |
No dataDYAI / S&P / -27.10% |
| 2020-Q21/2 |
WinDYAI / S&P 66.54% / 20.54% |
LoseDYAI / S&P -0.91% / -0.46% |
No dataDYAI / S&P / -27.11% |
| 2020-Q12/2 |
WinDYAI / S&P 0.39% / -19.60% |
WinDYAI / S&P 5.30% / 3.47% |
No dataDYAI / S&P / -14.75% |
| 2019-Q41/2 |
LoseDYAI / S&P -15.50% / 9.07% |
WinDYAI / S&P 29.77% / 5.36% |
No dataDYAI / S&P / 2.99% |
| 2019-Q30/1 |
LoseDYAI / S&P -2.08% / 1.70% |
No dataDYAI / S&P / 5.02% |
No dataDYAI / S&P / 0.21% |
| 2019-Q21/1 |
WinDYAI / S&P 92.62% / 4.30% |
No dataDYAI / S&P / 6.64% |
No dataDYAI / S&P / 8.65% |
| 2019-Q11/1 |
WinDYAI / S&P 71.96% / 13.65% |
No dataDYAI / S&P / 8.12% |
No dataDYAI / S&P / 14.29% |
| 2018-Q41/1 |
WinDYAI / S&P 11.83% / -13.52% |
No dataDYAI / S&P / 9.05% |
No dataDYAI / S&P / 18.23% |
| 2018-Q31/1 |
WinDYAI / S&P 12.67% / 7.71% |
No dataDYAI / S&P / 10.21% |
No dataDYAI / S&P / 19.06% |
| 2018-Q20/1 |
LoseDYAI / S&P -1.96% / 3.43% |
No dataDYAI / S&P / 9.03% |
No dataDYAI / S&P / 14.46% |
| 2018-Q11/1 |
WinDYAI / S&P 10.07% / -0.76% |
No dataDYAI / S&P / 7.68% |
No dataDYAI / S&P / 12.46% |
| 2017-Q40/1 |
LoseDYAI / S&P -6.71% / 6.64% |
No dataDYAI / S&P / 7.03% |
No dataDYAI / S&P / 13.82% |
| 2017-Q31/1 |
WinDYAI / S&P 8.76% / 4.48% |
No dataDYAI / S&P / 5.68% |
No dataDYAI / S&P / 17.57% |
| 2017-Q20/1 |
LoseDYAI / S&P -3.52% / 3.09% |
No dataDYAI / S&P / 4.83% |
No dataDYAI / S&P / 17.74% |
| 2017-Q10/1 |
LoseDYAI / S&P -14.46% / 6.07% |
No dataDYAI / S&P / 3.67% |
No dataDYAI / S&P / 13.32% |
| 2016-Q41/1 |
WinDYAI / S&P 10.67% / 3.82% |
No dataDYAI / S&P / 2.09% |
No dataDYAI / S&P / 7.05% |
| 2016-Q30/1 |
LoseDYAI / S&P -5.66% / 3.85% |
No dataDYAI / S&P / 0.20% |
No dataDYAI / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DYAI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -30.43% | 20.78% |
| Annualized return | -30.43% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DYAI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.69% | 83.14% |
| Annualized return | -36.52% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | DYAI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -54.93% | 319.30% |
| Annualized return | -7.66% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |